|
시장보고서
상품코드
2052317
줄기세포 치료 시장 : 세포원별, 용도별, 최종사용자별, 지역별Stem Cell Therapy Market, By Cell Source, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
줄기세포 치료 시장은 2026년에 228억 9,000만 달러로 추정되며, 2033년까지 975억 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 23.0%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 228억 9,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 23.00% | 2033년 시장 규모 예측: | 975억 달러 |
줄기세포 치료는 줄기세포와 그 파생세포를 이용하여 손상된 조직과 세포를 복구하거나 재생하는 재생의료의 유망한 신흥 분야입니다. 줄기세포는 생후 얼마 되지 않은 시기부터 모든 인간에게 존재합니다. 이들은 세포분열을 통해 스스로를 갱신하고 다양한 종류의 전문화된 세포로 분화할 수 있는 고유한 능력을 가지고 있습니다. 이 세포들은 이식이나 조직 재생을 통해 많은 난치병을 치료할 수 있는 큰 잠재력을 가지고 있습니다. 줄기세포 연구는 줄기세포가 가진 자연의 힘을 활용하여 암, 당뇨, 심장병, 골관절염, 신경질환 등 다양한 질병을 치료할 수 있는 치료제를 개발하는 것을 목표로 하고 있습니다.
시장 역학
세계 줄기세포 치료 시장의 성장은 만성질환 유병률 증가, 줄기세포 치료 성공률 향상, 재생의료의 급속한 발전, 줄기세포 치료 연구개발에 대한 투자 확대, 새로운 치료법 승인 등의 요인에 의해 주도되고 있습니다. 그러나 줄기세포의 연구개발 및 치료 적용에 따른 높은 비용과 배아줄기세포와 관련된 윤리적 문제는 시장 성장을 저해할 수 있습니다. 새로운 줄기세포 공급원의 출현, 줄기세포를 효율적으로 생산할 수 있는 첨단 기술 플랫폼의 개발, 맞춤형 줄기세포 치료제의 신속한 개발을 위한 인공지능의 적용은 향후 시장 성장의 기회를 가져올 수 있습니다. 전 세계적으로 저렴한 줄기세포 치료제를 제공하고, 줄기세포은행을 위한 효율적인 기술을 개발하는 것은 미충족 수요를 충족시키고 시장 범위를 확대하는 데 도움이 될 것입니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 세계 줄기세포 치료제 시장의 주요 기업 프로파일을 작성하기 위해 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략 등의 매개 변수를 기반으로 작성되었습니다.
- 주요 기업으로는 Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co., Ltd, Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Cellular Biomedicine Group, ANTEROGEN. C.O., LTD., NuVasive Inc., RTI Surgical, AlloSource 등이 있습니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 세계 줄기세포 치료 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 줄기세포 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 줄기세포 치료 시장 : 세포원별, 2021-2033년
제5장 세계의 줄기세포 치료 시장 : 용도별, 2021-2033년
제6장 세계의 줄기세포 치료 시장 : 최종사용자별, 2021-2033년
제7장 세계의 줄기세포 치료 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고문헌 및 조사 방법
KSM 26.06.11Stem Cell Therapy Market is estimated to be valued at USD 22.89 Bn in 2026 and is expected to reach USD 97.50 Bn by 2033, growing at a compound annual growth rate (CAGR) of 23.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 22.89 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 23.00% | 2033 Value Projection: | USD 97.50 Bn |
Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a very early stage of life. These have the unique ability to renew themselves through cell division and differentiate into a diverse range of specialized cell types. These cells hold great potential to treat many incurable diseases through transplantation or tissue regeneration. Stem cell research aims to harness the natural powers of stem cells to develop therapies that can cure various diseases like cancer, diabetes, heart disease, osteoarthritis and neurological disorders.
Market Dynamics
Global stem cell therapy market growth is driven by factors such as rising prevalence of chronic diseases, increasing success rates of stem cell therapies, rapid advancements in regenerative medicine, growing investments for research and development in stem cell therapies and approval of new therapies. However, high costs involved in stem cell research & development and therapeutic applications along with ethical issues related to embryonic stem cells can hamper the market growth. Emergence of new stem cell sources, development of advanced technology platforms for efficient production of stem cells, and application of artificial intelligence for faster development of customized stem cell therapies can offer opportunities for the market growth in the future. Providing affordable stem cell therapies globally and developing efficient techniques for stem cell banking can help to address unmet needs and expand the market reach.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global stem cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co., Ltd, Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Cellular Biomedicine Group, ANTEROGEN. C.O., LTD., NuVasive Inc., RTI Surgical, AlloSource.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global stem cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell therapy market.
Market Segmentation
- Cell Source Insights (Revenue, USD Bn, 2021 - 2033)
- Adult Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Musculoskeletal Disorders
- Wounds and Injuries
- Cancer
- Autoimmune Disorders
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Cell Banks
- Academic and Research Institutes
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Osiris Therapeutics, Inc.
- Kolon TissueGene, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Anterogen Co. Ltd.
- Pharmicell Co., Inc.
- Stemedica Cell Technologies, Inc.
- Magellan
- Medipost Co., Ltd.
- Athersys Inc.
- Biorestorative Therapies Inc.
- Brainstorm Cell Limited.
- ViaCyte Inc.
- Cellular Biomedicine Group
- ANTEROGEN. C.O., LTD.
- NuVasive Inc.
- RTI Surgical
- AlloSource
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Cell Source
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Stem Cell Therapy Market, By Cell Source, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Adult Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Induced Pluripotent Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Embryonic Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Stem Cell Therapy Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Musculoskeletal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Wounds and Injuries
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Stem Cell Therapy Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cell Banks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Stem Cell Therapy Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Osiris Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kolon TissueGene, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- JCR Pharmaceuticals Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anterogen Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharmicell Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stemedica Cell Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Magellan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medipost Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Athersys Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biorestorative Therapies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Brainstorm Cell Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ViaCyte Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cellular Biomedicine Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ANTEROGEN. C.O., LTD.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NuVasive Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RTI Surgical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AlloSource
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Osiris Therapeutics, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
